Inventor · disambiguated record
Brian R. Sloat
Also filed as: SLOAT BRIAN · SLOAT BRIAN R
4 granted patents·7 pending applications·8 citations·filing 2013–2024
68Inventor score
Technology areasA61K
Top patents by PatentIndex Score
11 records- 0189US11020403B2Precipitation resistant small molecule drug formulationsXERIS PHARMACEUTICALS INC·Filed 2018·Granted Jun 1, 2021·4 cites·22 claims
- 0283US11260033B2Compositions for the delivery of therapeutic agents and methods of use and making thereofDISRUPTION LABS INC·Filed 2021·Granted Mar 1, 2022·2 cites·15 claims
- 0369US9211260B2Methods of reducing the effects of exposure to a mustard compound by administering RLIP76TERAPIO CORP·Filed 2013·Granted Dec 15, 2015·2 cites·22 claims
- 0466US11833157B2Precipitation resistant small molecule drug formulationsXERIS PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·0 cites·25 claims
- 0561US2022241217A1Compositions for the delivery of therapeutic agents and methods of use and making thereofDISRUPTION LABS INC·Filed 2022·Application pending·0 cites
- 0660US2021290562A1Compositions for the delivery of therapeutic agents and methods of use and making thereofDISRUPTION LABS INC·Filed 2019·Application pending·0 cites
- 0759US2025018043A1Compositions for supplementing products with therapeutic agents and method of use thereofDISRUPTION LABS INC·Filed 2024·Application pending·0 cites
- 0858US2023085357A1Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereofXERIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0950US2024374519A1Compositions for supplementing products with therapeutic agents and methods of use thereofDISRUPTION LABS INC·Filed 2022·Application pending·0 cites
- 1046US2023233466A1Compositions for supplementing products with therapeutic agents and methods of use thereofDISRUPTION LABS INC·Filed 2021·Application pending·0 cites
- 1146US2023210771A1Compositions for the delivery of therapeutic agents and methods of use and making thereofDISRUPTION LABS INC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →